President Joe Biden and Vice President Kamala Harris tried to convince others through their plan for Americans with Medicare to lower prescription drug prices. The White House proclaimed that out-of-pocket costs a year will exceed $1.5 billion. Some of the drugs will start to cost less are Merck’s diabetes medication Januvia, Bristol Myers Squibb’s blood thinner Eliquis and Johnson & Johnson’s blood cancer drug Imbruvica. Tax penalties are in place for drug makers who refuse to participate in joining the Medicare drug system, and until 2029, 50 more drugs will be revealed for usage involving Medicare.